Fatty liver disease: Should you be tested?
Weight-loss drug may lower risk of heart attacks and infections
Testosterone therapy without evidence of deficiency may boost heart risk
Even a little exercise linked with lower stroke risk in people with afib
Antihistamines may not offer meaningful relief from eczema symptoms
What to eat on the DASH diet
Tricep workouts you can do at home
FDA approves first mRNA-based flu vaccine
Migraine: How it's diagnosed and what that means
Mindfulness practices to reduce stress and improve focus
Men's Health Archive
Articles
In search of better ways to find and treat prostate cancer
Biomarkers are molecular signatures of both normal and abnormal processes in the body. Here is a more formal definition proposed by a "definitions" working group associated with the National Institutes of Health: "A characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacological responses to a therapeutic intervention."
Proteins, fragments of proteins, enzymes, DNA, the RNA molecules that "read" DNA—they all can serve as biomarkers. Blood is an ideal source material because it's easy to collect and examine, but biomarkers can also be found in other body fluids, like urine, and in tissue itself. Biomarkers can inform decisions before, during, and after treatment.
Long-term statin use protects against prostate cancer death
Statins and other drugs that lessen cardiovascular disease risk by lowering blood lipids rank among the world’s most prescribed medications. And for the men who take them, accumulating evidence has for years pointed to another added benefit: a lower risk of developing prostate cancer. Now researchers are reporting that long-term statin use (more than 10 […]
Thriving with localized prostate cancer
There's a lot you can do to improve your outcome if you're taking an active surveillance approach to your diagnosis.
Image: © Nastasic/Getty Images
About 90% of men diagnosed with prostate cancer have the localized kind, which means the cancer is confined to the prostate gland. And for many, a reasonable approach is active surveillance, in which men choose to monitor their cancer instead of going straight into invasive treatments, such as surgery or radiation therapy.
Active surveillance includes a doctor visit about every six months, most often with a prostate-specific antigen (PSA) blood test and digital rectal exam.
Finding hidden risk for heart disease
These conditions are associated with a higher risk.
Image: © IvelinRadkov/Getty Images
Most men are familiar with the common strategies to reduce their heart disease risk: keep cholesterol in check, manage high blood pressure, follow a heart-healthy diet, and perform regular exercise. But there may be other preventive steps you can take.
"Some age-related conditions can further increase your risk without you knowing it, which is why it's important to be mindful about all aspects of your health," says Dr. Michael Gavin, a cardiologist with Harvard-affiliated Beth Israel Deaconess Medical Center. "Fortunately, once they are recognized, these other risk factors can be addressed and managed."
Smoking tied to more aggressive prostate cancer
If you’re a smoker looking for another reason to quit, consider this: in addition to raising your risk of heart and lung disease, as well as cancers of the bladder and kidney, smoking could boost the odds that you will develop aggressive prostate cancer that metastasizes, or spreads through your body. That’s according to research […]
Straight talk about your sex life
Although many older men enjoy active sex lives, most don't share sex-related questions and concerns with their doctor.
Image: © bernardbodo/Getty Images
While you discuss many subjects with your doctor, like proper blood pressure and cholesterol levels, your sex life probably doesn't make the list — but it should.
"Even though you may have an aging body, you can still feel healthy, vigorous, and full of life, and your sex life should be part of that," says Dr. Sharon Bober, director of the Sexual Health Program at Harvard-affiliated Dana-Farber Cancer Institute.
Investigators unveil metastatic prostate cancer’s genomic landscape
Localized prostate cancer that is diagnosed before it has a chance to spread typically responds well to surgery or radiation. But when a tumor metastasizes and sends malignant cells elsewhere in the body, the prognosis worsens. Better treatments for men with metastatic prostate cancer are urgently needed. In 2018, scientists advanced toward that goal by […]
A new option for immunotherapy in metastatic prostate cancer
Dividing cells face daunting challenges when replicating the billions of letters of DNA in their genomes. For instance, DNA letters in new cells can get mixed up, and then the affected genes don’t function correctly. To fix that problem, healthy cells can deploy so-called mismatch repair (MMR) genes that put scrambled DNA letters back in […]
Q&A with Dr. Daniel Rukstalis on prostatic urethral lift for enlarged prostates
A new procedure that relieves symptoms without causing sexual side effects As men get older, their prostates often get bigger and block the flow of urine out of the bladder. This condition, which is called benign prostatic hyperplasia, causes bothersome symptoms. Since men can’t fully empty their bladders, they experience sudden and frequent urges to […]
Fatty liver disease: Should you be tested?
Weight-loss drug may lower risk of heart attacks and infections
Testosterone therapy without evidence of deficiency may boost heart risk
Even a little exercise linked with lower stroke risk in people with afib
Antihistamines may not offer meaningful relief from eczema symptoms
What to eat on the DASH diet
Tricep workouts you can do at home
FDA approves first mRNA-based flu vaccine
Migraine: How it's diagnosed and what that means
Mindfulness practices to reduce stress and improve focus
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up